CA2989332A1 - Multivalent enterovirus vaccine compositions and uses related thereto - Google Patents

Multivalent enterovirus vaccine compositions and uses related thereto

Info

Publication number
CA2989332A1
CA2989332A1 CA2989332A CA2989332A CA2989332A1 CA 2989332 A1 CA2989332 A1 CA 2989332A1 CA 2989332 A CA2989332 A CA 2989332A CA 2989332 A CA2989332 A CA 2989332A CA 2989332 A1 CA2989332 A1 CA 2989332A1
Authority
CA
Canada
Prior art keywords
hrv
inactivated
virus
cells
valent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2989332A
Other languages
English (en)
French (fr)
Inventor
Martin L. MOORE
Sujin Lee
Minh Trang NGUYEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Childrens Healthcare of Atlanta Inc
Original Assignee
Emory University
Childrens Healthcare of Atlanta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University, Childrens Healthcare of Atlanta Inc filed Critical Emory University
Publication of CA2989332A1 publication Critical patent/CA2989332A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA2989332A 2015-06-15 2016-06-15 Multivalent enterovirus vaccine compositions and uses related thereto Abandoned CA2989332A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562175832P 2015-06-15 2015-06-15
US62/175,832 2015-06-15
PCT/US2016/037658 WO2016205389A1 (en) 2015-06-15 2016-06-15 Multivalent enterovirus vaccine compositions and uses related thereto

Publications (1)

Publication Number Publication Date
CA2989332A1 true CA2989332A1 (en) 2016-12-22

Family

ID=57546427

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2989332A Abandoned CA2989332A1 (en) 2015-06-15 2016-06-15 Multivalent enterovirus vaccine compositions and uses related thereto

Country Status (7)

Country Link
US (1) US11160857B2 (enExample)
EP (1) EP3307311A4 (enExample)
JP (2) JP6902195B2 (enExample)
KR (1) KR20180086180A (enExample)
CN (1) CN108025055B (enExample)
CA (1) CA2989332A1 (enExample)
WO (1) WO2016205389A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016205389A1 (en) * 2015-06-15 2016-12-22 Emory University Multivalent enterovirus vaccine compositions and uses related thereto
CN109337876A (zh) * 2018-10-15 2019-02-15 北京世纪元亨动物防疫技术有限公司 一种猪流行性腹泻病毒的纯化方法
EP3927372A4 (en) * 2019-02-21 2023-01-25 Centivax, Inc. OPTIMIZED VACCINE COMPOSITIONS AND METHODS OF PRODUCTION
CN115869324B (zh) * 2022-12-30 2024-02-27 湖北工业大学 Efavirenz在制备抗肠道病毒药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946676A (en) 1986-08-27 1990-08-07 De Staat Der Nederlanden Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
US5714374A (en) 1990-09-12 1998-02-03 Rutgers University Chimeric rhinoviruses
US20020086386A1 (en) 1997-03-04 2002-07-04 Kamb Carl Alexander B-catenin assays, and compositions therefrom
US20060088549A1 (en) 2004-07-08 2006-04-27 Arnold Gail F Chimeric virus vaccine
US8153760B2 (en) 2005-01-19 2012-04-10 Donald Danforth Plant Science Center Rhinovirus vaccines
US8652486B2 (en) * 2006-09-29 2014-02-18 Sanofi Pasteur Biologics, Llc Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications
JP2011517408A (ja) * 2008-03-27 2011-06-09 サノフィ パスツール バイオロジクス カンパニー 組換えライノウイルスベクター
US20120088814A1 (en) * 2009-03-31 2012-04-12 Isis Pharmaceuticals, Inc. Methods of modulating an immune response to a viral infection
CN102905728B (zh) * 2010-05-26 2015-11-25 西莱克塔生物科技公司 具有不偶合的佐剂的纳米载体组合物
EP2765137A1 (en) 2013-02-07 2014-08-13 Sanofi Pasteur Induction of cross-reactive cellular response against rhinovirus antigens
PT3010537T (pt) * 2013-06-17 2019-12-03 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport Métodos para a prevenção da agregação de componentes virais
JP6774149B2 (ja) * 2014-05-28 2020-10-21 ナショナル ヘルス リサーチ インスティテューツＮａｔｉｏｎａｌ Ｈｅａｌｔｈ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅｓ エンテロウイルス感染に対する免疫原としてのウイルス粒子およびその生産
WO2016205389A1 (en) * 2015-06-15 2016-12-22 Emory University Multivalent enterovirus vaccine compositions and uses related thereto

Also Published As

Publication number Publication date
JP6902195B2 (ja) 2021-07-14
CN108025055A (zh) 2018-05-11
US20180169215A1 (en) 2018-06-21
JP2018517722A (ja) 2018-07-05
US11160857B2 (en) 2021-11-02
KR20180086180A (ko) 2018-07-30
JP2021152024A (ja) 2021-09-30
EP3307311A4 (en) 2019-02-13
CN108025055B (zh) 2022-08-26
EP3307311A1 (en) 2018-04-18
WO2016205389A1 (en) 2016-12-22

Similar Documents

Publication Publication Date Title
KR101255016B1 (ko) 소포성 구내염 바이러스의 상승적 감쇠, 그의 벡터 및 그의 면역원성 조성물
US9737597B2 (en) Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins
AU2020244533B2 (en) Recombinant RSV with silent mutations, vaccines, and methods related thereto
CN105555958B (zh) 水疱性口炎病毒的改性基质蛋白
JP2021152024A (ja) 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用
CN116348132A (zh) 基于合成的被修饰的痘苗安卡拉（smva）的冠状病毒疫苗
JP2022523157A (ja) キメラ型ＲＳＶおよびｈＭＰＶ Ｆタンパク質、免疫原性組成物、ならびに使用方法
CN113382748A (zh) 用于制备和使用病毒样颗粒(vlp)的组合物和方法
US20260115277A1 (en) Immunogenic compositions for epstein-barr virus proteins
US20200308555A1 (en) Lassa vaccine
JP2016521567A (ja) 半生呼吸器合胞体ウイルスワクチン
WO2023165435A1 (zh) 重组刺突蛋白及其制备方法和用途
EP4574168A1 (en) Prime-boost immunization against influenza
CN117384962B (zh) 一种牛副流感病毒3型和牛病毒性腹泻病毒二联腺病毒载体疫苗及其应用
Zhang et al. Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector
CN116987736A (zh) 自复制rna分子和新冠病毒多价疫苗

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210608

FZDE Discontinued

Effective date: 20231128